1. Atkin, K., & Ahmad, W. I. U. (1998). Genetic screening and haemoglobinopathies: Ethics, politics, and practice. Soc Sci Med, 46, 445–458.
2. Cao, A., Furbetta, M., Galanello, M., Melis, A., Angius, A., Ximenes, A., et~al. (1981). Prevention of homozygous β-thalassemia by carrier screening and prenatal diagnosis in Sardinia. Amer J Hum Genet, 33, 592–605.
3. Cao, A., Pintua, L., Lecca, U., Olla, G., Cossu, P., Rosatelli, C., & Galanello, R. (1984). Control of homozygous β-Thalassemia by carrier screening and antenatal diagnosis in Sardinians. Clin Genet, 26, 12–22.
4. Cao, A., Rosatelli, C., Galanello, R., Monni, G., Olla, G., Cossu, P., & Ristaldi, M. (1989). The prevention of thalassemia in Sardinia. Clin Genet, 36, 277–285.
5. Cao, A., Saba, L., Galanello, R., & Rosatelli, M. (1997). Molecular diagnosis and carrier screening for β-thalassemia. J Amer Med Assoc, 278, 1273–1277.